A1LN34:BVMF
Alnylam Pharmaceuticals Inc Bdr
R$63.72
0.00%
(0.00) 1D
Sep 23, 12:13:00 PM GMT-3 · BRL
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1LN34...
Mkt. cap
34.25B
Avg. vol.
800.00
Volume
0.00
52-wk high
R$132.40
52-wk low
R$50.25
Shares outstanding
133.81M
No. of employees
2K
Mkt. cap
34.25B
Avg. vol.
800.00
Volume
0.00
52-wk high
R$132.40
52-wk low
R$50.25
Shares outstanding
133.81M
No. of employees
2K
News stories
From web sources and news partners
Investing.com Nigeria
·
12 hours ago
Form 4 Alnylam Pharmaceuticals Inc For: 27 September By Investing.com
https://www.dars.gov.et/
·
1 month ago
ALNY Q2 2026 Earnings: EPS Misses Estimates by 23.7%, Shares Edge Higher - Earnings Beat Streak
Profile
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
About Alnylam Pharmaceuticals Inc Bdr